4-氨基-2-甲基噻吩-3-甲酸甲酯 | 114943-05-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 中文名称: 4-氨基-2-甲基噻吩-3-甲酸甲酯
• 英文名称: methyl 4-amino-2-methylthiophene-3-carboxylate
• CAS: 114943-05-4
• 化学式: C₇H₉NO₂S
• 分子量: 171.22
• InChiKey: WGXXITACOCKKFJ-UHFFFAOYSA-N

物化性质

• 沸点：
  293.4±35.0 °C(Predicted)
• 密度：
  1.264±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  80.6
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  4-氨基-2-甲基噻吩-3-甲酸甲酯 在 碳酸氢钠 、 sodium iodide 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 63.0h， 生成
  参考文献：
  名称：

  噻吩系统。9.硫代嘧啶二酮衍生物作为潜在的降压药。

  摘要：

  一系列在N-3处被（苯基哌嗪基）烷基取代的噻吩并[3,4-d]-，噻吩并[3,2-d]-和噻吩并[2,3-d]嘧啶-2,4-二酮具有合成并评估自发性高血压大鼠（SHR）的降压作用。将这49种化合物与血管扩张剂标准prazosin和等排性喹唑啉-2,4-二酮SGB 1534进行了比较。研究了苯环在2、3或4位上的取代，以及在2位上的取代。比4-取代更有效，而异构的3-取代化合物的效力最低。与氢相比，N-1位的烷基化或酰化均未改善抗高血压作用。三个thienopyrimidine-2，发现在SHR中，剂量为（mg / kg，口服）的强效口服降压药为在N-3处含有[（2-甲氧基苯基）哌嗪基]乙基部分且在N-1处含有氢的4-二酮（3-5）。 ），以使收缩压（SBP）分别降低0.21、0.19和1.0的50 mmHg（ED-50SBP）。通过测量使SHR中的去氧肾上腺素升压反应拮抗50％（ED50）

  DOI：

  10.1021/jm00117a019

文献信息

• Condensed thienopyrimidines. I. Synthesis and gastric antisecretory activity of 2,3-dihydro-5H-oxazolothienopyrimidin-5-one derivatives.
  作者：Mitsuo SUGIYAMA、Toshiaki SAKAMOTO、Keiichi TABATA、Kazuo ENDO、Keiichi ITO、Mitsuko KOBAYASHI、Hiroshi FUKUMI

  DOI：10.1248/cpb.37.2091

  日期：——

  A practical preparation of various 2, 3-dihydro-5H-oxazolo[3, 2-a]thieno[3, 2-d]-, [3, 4-d]-, and [2, 3-d]pyrimidin-5-one derivatives was developed starting from the corresponding aminothiopheneesters in two steps, and their chloro-substituted derivatives were prepared. These compounds were evaluated for gastric antisecretory activity in pylorus-ligated rats, compared to the anti-ulcer standard, cimetidine, and their structure-activity relationships are discussed.

  一种实用的方法被开发用于合成多种2, 3-二氢-5H-噁唑并噻吩的[3, 2-a]、[3, 4-d]和[2, 3-d]嘧啶-5-酮衍生物，该过程从相应的氨基噻吩酯出发，仅需两步，并且其氯取代衍生物也被合成。这些化合物在幽门结扎大鼠中评估了其抗胃分泌活性，并与抗溃疡标准药物西咪替丁进行了比较，同时讨论了它们的结构-活性关系。
• Condensed thienopyrimidines. II. Synthesis and gastric antisecretory activity of thiazole and polymethylene condensed thienopyrimidine derivatives.
  作者：Mitsuo SUGIYAMA、Toshiaki SAKAMOTO、Keiichi TABATA、Kazuo ENDO、Keiichi ITO、Mitsuko KOBAYASHI、Hiroshi FUKUMI

  DOI：10.1248/cpb.37.2122

  日期：——

  Thiazolo[3, 2-a]thieno[3, 2-d]-, [3, 4-d]- and [2, 3-d]pyrimidin-5-one derivatives (6, 11, and 16), and polymethylene condensed thieno[3, 2-d]-, [3, 4-d]- and [2, 3-d]pyrimidin-5-one derivatives (19-21), in which the oxygen atom of the oxazolidine moiety in 3 was replaced by a sulfur atom or methylene groups, were synthesized and evaluated for gastric antisecretory activity in pylorus-ligated rats. The structure-activity relationships of these compounds are discussed.

  合成并评估了噻唑并噻吩和嘧啶-5-酮衍生物（6、11和16）以及多亚甲基缩合的噻吩-和嘧啶-5-酮衍生物（19-21），其中在3的噁唑烷环中的氧原子被硫原子或亚甲基取代，并对在幽门结扎大鼠中进行的胃抗分泌活性进行了评估。文中讨论了这些化合物的结构-活性关系。
• Kynurenic Acid Derivatives Inhibit the Binding of Nerve Growth Factor (NGF) to the Low-Affinity p75 NGF Receptor
  作者：Juan C. Jaen、Edgardo Laborde、Ruth A. Bucsh、Bradley W. Caprathe、Roderick J. Sorenson、James Fergus、Katharyn Spiegel、James Marks、Melvin R. Dickerson、Robert E. Davis

  DOI：10.1021/jm00022a008

  日期：1995.10

  The ability of a series of substituted kynurenic acids, thienopyridinonecarboxylic acids, and related compounds to inhibit the binding of nerve growth factor (NGF) to the p75 NGF receptor (NGFR) was evaluated in a radioligand binding assay that utilized a biotinylated derivative of the extracellular domain of p75 NGFR (p75(ext)) fixed to streptavidin-coated plastic wells. Two compounds, 6-aminokynurenic acid (5h) and the 3-methyl ester of 4,7-dihydro-2-methyl-7-oxo-thieno[3,2-b]pyridine-3,5-dicarboxylic acid (16), were found to inhibit the binding of [I-125]NGF to p75(ext) with IC50 values in the low micromolar range. Other amino-substituted kynurenic acids also possessed activity at slightly higher concentrations. Several structural features seem to be essential, including the carboxylic acid, a polar group on the benzene ring (or thiophene ring, in the case of analogues of 16), and the C-4 carbonyl group in the pyridinone ring. These compounds were also found to inhibit the binding of [I-125]NGF to its receptors in membranes from PC12 cells (which express p75 as well as trk(a) receptors for NGF) and DG44-CHO cells (transfected with full length p75 NGFR). The available data for 5h and 16 do not allow the determination of whether the effects of these compounds are mediated by their interaction with NGF or the NGF receptors.
• PRESS, JEFFREY B.;RUSSELL, RONALD K.
  作者：PRESS, JEFFREY B.、RUSSELL, RONALD K.

  DOI：——

  日期：——
• SUGIYAMA, MITSUO;SAKAMOTO, TOSHIAKI;TABATA, KEIICHI;ENDO, KAZUO;ITO, KEII+, CHEM. AND PHARM. BULL., 37,(1987) N, C. 2091-2102
  作者：SUGIYAMA, MITSUO、SAKAMOTO, TOSHIAKI、TABATA, KEIICHI、ENDO, KAZUO、ITO, KEII+

  DOI：——

  日期：——